Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU1 and SP1 sites

The gene defective in X-linked agammaglobulinemia (XLA) encodes a novel protein kinase termed Bruton's tyrosine kinase (Btk). Whereas the XLA phenotype is confined to abnormalities of B-cell development and function, Btk is expressed not only in B-lymphocyte lineage but also in myeloid lineage cells. The first 450 basepairs of the Btk promoter fused to a luciferase gene displayed a similar cell-type specificity. Critical binding sites for the transcription factors PU.1 and Spl were identified in the proximal portion of the Btk promoter upstream of a cluster of transcriptional start sites, Mutation of either the PU.1 or Sp1 site markedly reduced the activity of a Btk promoter-luciferase reporter construct in transfection experiments, In addition, PU.1 directly transactivated the Btk promoter, and deletion of the PU.1 binding site abolished this effect, This study implicates PU.1 and Sp1 as major regulators of Btk expression and provides a foundation for further study of the regulation of this gene in XLA patients that lack Btk mRNA. This is a US government work, There are no restrictions on its use.